Caledonia Investments (LSE:CLDN)

Caledonia's investment objective is to consistently achieve a long-term shareholder return in excess of the FTSE All-Share Total Return, while maintaining a progressive annual dividend.

Related Articles

• Friday, 12th July, 2019 | Harvey Jones

  Forget buy-to-let! I’d buy these 3 investment trusts for growth and income

  Buy-to-let is a bother, but these investment trusts make investing for income and growth much easier, says Harvey Jones. Read More »

• Wednesday, 29th May, 2019 | Alan Oscroft

  Investing for dividends? I’d consider these income champion investment trusts

  These two investment trusts have lifted their dividends for 52 and 45 years in a row, respectively. Read on to find out who they... Read More »

• Friday, 22nd February, 2019 | Alan Oscroft

  Looking to invest £2,000? Here are two investment trusts I’d consider

  I think investment trusts are a great way to start your portfolio. Here are two at the top of my list. Read More »

• Thursday, 1st November, 2018 | The Motley Fool Staff

  Top shares for November

  We asked our writers to share their top stock picks for the month. Read More »

• Tuesday, 23rd October, 2018 | Alan Oscroft

  2 investment trusts I’d pick for a starter pension portfolio today

  If I was starting out now building my pension portfolio, these are two investment trusts I'd seriously consider. Read More »

• Monday, 28th May, 2018 | G A Chester

  2 investment trusts I’d buy to beat the FTSE 100

  These two neglected investment trusts look set to outperform the FTSE 100 (INDEXFTSE:UKX), says G A Chester. Read More »

• Wednesday, 28th February, 2018 | Rupert Hargreaves

  Is this an unmissable opportunity to snap up these 2 global investment trusts?

  These globally diversified investment trusts could add extra profits to your portfolio. Read More »

• Sunday, 3rd December, 2017 | Jack Tang

  Looking for steady income? Consider these dividend investment trusts

  These dividend investment trusts could offer safe, predictable, and growing income. Read More »

• Thursday, 23rd November, 2017 | Roland Head

  This FTSE 100-beating investment trust could be a better buy than GlaxoSmithKline plc

  Roland Head suggests a long-term alternative to FTSE 100 (INDEXFTSE:UKX) pharma giant GlaxoSmithKline plc (LON:GSK). Read More »

• Thursday, 13th July, 2017 | G A Chester

  2 undervalued mid-caps that could help you retire early

  These two stocks have stunning potential, says G A Chester. Read More »